Enovis EBITDA 2010-2025 | ENOV
Enovis ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Enovis Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $159 |
| 2023 | $151 |
| 2022 | $149 |
| 2021 | $200 |
| 2020 | $180 |
| 2019 | $440 |
| 2018 | $300 |
| 2017 | $452 |
| 2016 | $380 |
| 2015 | $420 |
| 2014 | $584 |
| 2013 | $526 |
| 2012 | $323 |
| 2011 | $49 |
| 2010 | $51 |
| 2009 | $55 |
| Enovis Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $25 |
| 2024-12-31 | $60 |
| 2024-09-30 | $39 |
| 2024-06-30 | $22 |
| 2024-03-31 | $38 |
| 2023-12-31 | $51 |
| 2023-09-30 | $35 |
| 2023-06-30 | $39 |
| 2023-03-31 | $27 |
| 2022-12-31 | $24 |
| 2022-09-30 | $32 |
| 2022-06-30 | $57 |
| 2022-03-31 | $35 |
| 2021-12-31 | $-32 |
| 2021-09-30 | $53 |
| 2021-06-30 | $56 |
| 2021-03-31 | $124 |
| 2020-12-31 | $-105 |
| 2020-09-30 | $123 |
| 2020-06-30 | $57 |
| 2020-03-31 | $105 |
| 2019-12-31 | $137 |
| 2019-09-30 | $138 |
| 2019-06-30 | $117 |
| 2019-03-31 | $47 |
| 2018-12-31 | $47 |
| 2018-09-30 | $74 |
| 2018-06-30 | $80 |
| 2018-03-31 | $99 |
| 2017-12-31 | $145 |
| 2017-09-30 | $108 |
| 2017-06-30 | $107 |
| 2017-03-31 | $92 |
| 2016-12-31 | $93 |
| 2016-09-30 | $92 |
| 2016-06-30 | $109 |
| 2016-03-31 | $86 |
| 2015-12-31 | $90 |
| 2015-09-30 | $85 |
| 2015-06-30 | $131 |
| 2015-03-31 | $114 |
| 2014-12-31 | $153 |
| 2014-09-30 | $162 |
| 2014-06-30 | $151 |
| 2014-03-31 | $119 |
| 2013-12-31 | $152 |
| 2013-09-30 | $134 |
| 2013-06-30 | $137 |
| 2013-03-31 | $102 |
| 2012-12-31 | $84 |
| 2012-09-30 | $98 |
| 2012-06-30 | $104 |
| 2012-03-31 | $38 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $11 |
| 2011-06-30 | $24 |
| 2011-03-31 | $17 |
| 2010-12-31 | $25 |
| 2010-09-30 | $13 |
| 2010-06-30 | $9 |
| 2010-03-31 | $5 |
| 2009-12-31 | $14 |
| 2009-09-30 | $14 |
| 2009-06-30 | $12 |
| 2009-03-31 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.805B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.172B | 60.28 |
| Hims & Hers Health (HIMS) | United States | $11.812B | 122.72 |
| Tempus AI (TEM) | United States | $10.155B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.637B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.007B | 62.61 |
| Hinge Health (HNGE) | United States | $3.004B | 0.00 |
| Privia Health (PRVA) | United States | $2.780B | 190.00 |
| Schrodinger (SDGR) | United States | $1.749B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.446B | 25.51 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.544B | 162.50 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.378B | 0.00 |
| Outset Medical (OM) | United States | $0.356B | 0.00 |
| TruBridge (TBRG) | United States | $0.353B | 784.00 |
| Health Catalyst (HCAT) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.120B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.072B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |